Olpasiran
amgen
['cardio']
olpasiran therapy significantly reduced lipoprotein(a) concentrations in patients with established #ascvd, based on findings from the ocean(a) dose trial presented at #aha22. get the details: #cardiotwitter 
Official account of the American College of Cardiology. Join us to transform cardiovascular care & improve heart health. Find us: @JACCJournals @Cardiology